AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 75 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $662,000 | +57.2% | 19,214 | -23.7% | 0.00% | +50.0% |
| Q2 2020 | $421,000 | +28.0% | 25,175 | +10.5% | 0.00% | 0.0% |
| Q1 2020 | $329,000 | -34.6% | 22,791 | +51.6% | 0.00% | 0.0% |
| Q4 2019 | $503,000 | +23.9% | 15,032 | -22.5% | 0.00% | 0.0% |
| Q3 2019 | $406,000 | +78.1% | 19,403 | +76.9% | 0.00% | +100.0% |
| Q2 2019 | $228,000 | -4.6% | 10,970 | +2.7% | 0.00% | 0.0% |
| Q1 2019 | $239,000 | +18.3% | 10,677 | +99.7% | 0.00% | 0.0% |
| Q4 2017 | $202,000 | -63.7% | 5,346 | -85.6% | 0.00% | -80.0% |
| Q3 2016 | $556,000 | +12.3% | 37,050 | -19.0% | 0.01% | 0.0% |
| Q2 2016 | $495,000 | – | 45,750 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,295,712 | $47,524,000 | 3.98% |
| Samsara BioCapital, LLC | 232,571 | $3,354,000 | 1.93% |
| Eventide Asset Management | 3,851,000 | $55,531,000 | 1.80% |
| Burrage Capital Management LLC | 112,546 | $1,609,000 | 1.58% |
| Avidity Partners Management LP | 408,000 | $5,883,000 | 0.81% |
| RICE HALL JAMES & ASSOCIATES, LLC | 982,484 | $14,167,000 | 0.79% |
| Bullseye Asset Management LLC | 43,374 | $626,000 | 0.75% |
| Nantahala Capital Management | 1,005,302 | $14,496,000 | 0.54% |
| ARMISTICE CAPITAL, LLC | 600,000 | $8,652,000 | 0.54% |
| Values First Advisors, Inc. | 27,042 | $389,947 | 0.47% |